Evidence map›Paper›PMID 38771359›Full record

ArticleCurrent microbiology2024

Screening Antibacterial Photodynamic Effect of Monascus Red Yeast Rice (Hong-Qu) and Mycelium Extracts.

Marketa Husakova, Viviana Teresa Orlandi, Fabrizio Bolognese, Barbora Branska, Petra Patakova

Abstract read
In one paragraph

Article in Current microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Pigment Formation byJournal of agricultural and food chemistry · 2025
    Article
  4. PurifiedJournal of natural products · 2025
    Review
  5. Coordinated Synthesis of Pigments Differing in Side Chain Length inJournal of agricultural and food chemistry · 2025
    Article
  6. Article
  7. Clinical pharmacology : advances and applications · 2025
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marketa HusakovaDepartment of Biotechnology, University of Chemistry and Technology Prague, Technicka 5, 160 00, Prague, Czech Republic.ORCID http://orcid.org/0000-0001-6120-307X
Viviana Teresa OrlandiDepartment of Biotechnologies and Life Sciences, University of Insubria, Via JH Dunant 3, 21100, Varese, Italy.ORCID http://orcid.org/0000-0001-6010-2840
Fabrizio BologneseDepartment of Biotechnologies and Life Sciences, University of Insubria, Via JH Dunant 3, 21100, Varese, Italy.
Barbora BranskaDepartment of Biotechnology, University of Chemistry and Technology Prague, Technicka 5, 160 00, Prague, Czech Republic.ORCID http://orcid.org/0000-0001-6536-7063
Petra PatakovaDepartment of Biotechnology, University of Chemistry and Technology Prague, Technicka 5, 160 00, Prague, Czech Republic. petra.patakova@vscht.cz.ORCID http://orcid.org/0000-0002-9410-4454

Funding

Vysoká Škola Chemicko-technologická v Praze A2_FPBT_2022_016
6 · The paper itself

Abstract

The fungus Monascus is a well-known source of secondary metabolites with interesting pharmaceutical and nutraceutical applications. In particular, Monascus pigments possess a wide range of biological activities (e.g. antimicrobial, antioxidant, anti-inflammatory or antitumoral). To broaden the scope of their possible application, this study focused on testing Monascus pigment extracts as potential photosensitizing agents efficient in antimicrobial photodynamic therapy (aPDT) against bacteria. For this purpose, eight different extracts of secondary metabolites from the liquid- and solid-state fermentation of Monascus purpureus DBM 4360 and Monascus sp. DBM 4361 were tested against Gram-positive and Gram-negative model bacteria, Bacillus subtilis and Escherichia coli and further screened for ESKAPE pathogens, Staphylococcus aureus and Pseudomonas aeruginosa. To the bacterial culture, increasing concentration of extracts was added and it was found that all extracts showed varying antimicrobial activity against Gram-positive bacteria in dark, which was further increased after irradiation. Gram-negative bacteria were tolerant to the extracts' exposure in the dark but sensitivity to almost all extracts that occurred after irradiation. The Monascus sp. DBM 4361 extracts seemed to be the best potential candidate for aPDT against Gram-positive bacteria, being efficient at low doses, i.e. the lowest total concentration of Monascus pigments exhibiting aPDT effect was 3.92 ± 1.36 mg/L for E. coli. Our results indicate that Monascus spp., forming monascuspiloin as the major yellow pigment and not-forming mycotoxin citrinin, is a promising source of antimicrobials and photoantimicrobials.

Indexed as

Anti-Bacterial AgentsMicrobial Sensitivity TestsMonascusMyceliumBiological ProductsComplex MixturesGram-Positive BacteriaPhotochemotherapyPhotosensitizing AgentsPigments, BiologicalAnti-Bacterial AgentsBiological ProductsComplex MixturesPhotosensitizing AgentsPigments, Biologicalred yeast rice

Identifiers

PMID38771359
PMCPMC11108928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.